| 标题： | 示卓安肝脏超声造影中国临床应用专家共识 |
| title： | Experts consensus on the clinical application of liver contrast-enhanced US with Sonazoid in China |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 综合 |
| field： | Comprehensive guideline |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 各级医疗机构从事肝脏诊疗相关工作的超声医生和临床医生 |
| Guide users： | Sonographers and clinicians involved in the clinical care of liver diseases from medical institutions at all levels |
| 证据分级方法： | GRADE证据分级标准 |
| Evidence grading method： | Grading of Recommendations Assessment, Development and Evaluation (GRADE) |
| 制定单位： | 中华医学会超声医学分会 |
| Formulating unit： | Chinese Society of Ultrasound in Medicine |
| 注册时间： | 2024-04-02 |
| Registration time： | |
| 注册编号： | PREPARE-2024CN484 |
| Registration number： | |
| 指南制订的目的： | 示卓安是枯否细胞特异性造影剂，示卓安超声造影在肝脏疾病筛查、诊断、术中及介入、疗效评估中发挥重要作用，但目前示卓安超声尚无示卓安超声造影在肝脏疾病中的综合管理指南或专家共识，本专家共识旨在规范示卓安超声造影在肝脏疾病中的应用。 |
| Purpose of the guideline： | Sonazoid is a Kupffer-cell specific contrast agent. Contrast-enhanced US with Sonazoid plays a very important role in the screening, diagnosis, intraoperative and interventional procedures, and efficacy assessment of liver diseases. We aimed to standardize the use of contrast-enhanced US with Sonazoid in the management of liver disease in the experts consensus. |
最新注册
